We have located links that may give you full text access.
CASE REPORTS
JOURNAL ARTICLE
Complete Response of Metastatic Melanoma to Second Line Chemotherapy with Paclitaxel and Carboplatin - Case Report.
Acta Medica Academica 2018 May
OBJECTIVE: We present a patient with metastatic melanoma who had a complete response to second line chemotherapy with paclitaxel and carboplatin.
CASE REPORT: Metastatic melanoma is an aggressive cancer with poor prognosis and 10 year survival less than 10%. We present a patient with metastatic melanoma who had a complete response to second line chemotherapy with paclitaxel and carboplatin.
CONCLUSION: Second line chemotherapy with paclitaxel and carboplatin in the treatment of metastatic melanoma may yield effective results.
CASE REPORT: Metastatic melanoma is an aggressive cancer with poor prognosis and 10 year survival less than 10%. We present a patient with metastatic melanoma who had a complete response to second line chemotherapy with paclitaxel and carboplatin.
CONCLUSION: Second line chemotherapy with paclitaxel and carboplatin in the treatment of metastatic melanoma may yield effective results.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices 
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app